Healing Hearts Changing Minds

What Healing Hearts Changing Minds does

Healing Hearts, Changing Minds, Inc. (HHCM) is a nonprofit 501(c)(3) foundation headquartered in Derry, New Hampshire, founded in 2023 by Robert Ansin following his transformative experience at a psilocybin retreat in Jamaica. The organization operates exclusively as a grantmaking foundation rather than a product or service vendor, channeling donations from individuals (many with personal psychedelic experience) into competitive grants that fund psychedelic-assisted therapy research and care delivery. HHCM employs a trust-based philanthropy model, conducting structured listening tours with field leaders before issuing Requests for Proposals, and evaluates proposals using its proprietary Ripple Model of Good Effects framework that assesses impact at individual, community, and systemic levels.

Name

Healing Hearts Changing Minds

Legal name

Healing Hearts, Changing Minds, Inc.

Website

https://healingheartsminds.org

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Healing Hearts, Changing Minds is a 501(c)(3) grantmaking foundation funding psychedelic-assisted therapy research and care delivery. It serves palliative patients, LGBTQIA+ communities, veterans, and rural populations via competitive grants to grantees including Mayo Clinic and leading hospices.

Ownership category

akta.pro rank

Product category

Nonprofit Grantmaking Foundation

NAICS

Grantmaking Foundations (813211), Voluntary Health Organizations (813212)

SIC

Services-Social Services (8300)

akta.pro primary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

akta.pro secondary industry

Palliative Care, Hospice & Serious Illness Support (BPAGACAK)

Keywords

• Psychedelic therapy grants
• Nonprofit foundation funding
• End-of-life care philanthropy
• Palliative care grants
• Mental health grantmaking

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Others

Revenue model

1. Donations and Charitable Contributions: HHCM is a 501(c)(3) nonprofit that relies on donations from individuals who have had transformative psychedelic experiences. The founder, Robert Ansin, drew on personal experience and his real estate business to fund the organization. Donors are encouraged to view giving as an extension of their own psychedelic integration journey.
2. Grant Disbursements: HHCM disburses funds through competitive grant rounds. The 2026 round 'Walking Each Other Home' awarded $566,260 to seven projects. The 2024 round awarded over $500,000 to six nonprofit partners focused on LGBTQ+ affirming psychedelic care.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Healing Hearts, Changing Minds is a nonprofit grantmaking foundation that funds psychedelic-assisted therapy research and care delivery through competitive RFP-driven grant rounds. It disburses philanthropic capital to healthcare institutions, hospices, academic medical centers, and community-based nonprofits working on end-of-life care, palliative care, LGBTQIA+ affirming psychedelic care, and trauma-informed programs involving psilocybin and ketamine-assisted therapy.

Product overview

Healing Hearts, Changing Minds is a nonprofit foundation (501(c)(3)) that operates as a grant-making organization rather than a traditional product company. The organization offers grant programs that fund psychedelic-assisted therapy research and care delivery, primarily through its 'Walking Each Other Home' fund which provides grants to healthcare institutions, hospices, and research organizations. The core offering consists of grant programs that support end-of-life care, palliative care, and psychedelic therapy research, including funding for ketamine-assisted psychotherapy and psilocybin clinical trials at institutions like the Mayo Clinic and University of Washington.

Differentiator

Problem solved

Functional benefit

Products and services

• Walking Each Other Home Grant Fund A philanthropic grantmaking program that funds innovative projects advancing psychedelic-assisted end-of-life care. Awards grants to organizations conducting research and delivering care to palliative and hospice patients, with a competitive RFP-driven review process involving independent subject matter experts.
• 2024 LGBTQ+ Affirming Psychedelic Care Grants Foundational grant round funding six nonprofit partners including SafeHouse 7, Flourish (Columbia University), Heroic Hearts Project, Berkeley Center for the Science of Psychedelics, Integrate, and Naropa University to expand access to psychedelic-assisted therapy for LGBTQIA+ communities, totaling over $500,000.

Quantifiable outcome

• Awarded $566,260 to 7 projects in the 2026 grant round from 59 submitted proposals requesting $4.8 million total, representing a 12% acceptance rate.
• +2 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

17 partnerships are on record, tiered core and minor.

• End of Life Psychedelic Care (EOLPC)coreStrategic or Co-development Partner · 27 January 2026EOLPC, based in Ashland, Oregon, is the lead organization in a $75,025 grant collaboration with the Institute for Rural Psychedelic Care (IRPC) and Ligare. The partnership delivers home-based ketamine therapy integrated with spiritual care from doulas and chaplains for hospice and palliative patients across three sites in the US. EOLPC founder Christine Caldwell is a key research leader on the project.
• Institute for Rural Psychedelic Care (IRPC)coreStrategic or Co-development Partner · 27 January 2026IRPC in Arcata, California is a key partner in two HHCM-funded projects: (1) a collaboration with EOLPC and Ligare delivering home-based ketamine therapy, and (2) a standalone $87,700 grant to provide KAP and narrative medicine programs for terminally ill patients in rural communities, including documentary filmmaking for legacy building. Research leaders include Michael Fratkin, MD and Carrie Griffin, OD.
• LigarecoreStrategic or Co-development Partner · 27 January 2026Ligare, based in Savannah, Georgia, is a partner in the Home-Based Psychedelic and Spiritual Care (HBPS) pilot alongside EOLPC and IRPC. The collaboration aims to deliver home-based ketamine therapy integrated with spiritual care to hospice and palliative patients across three sites.
• Mayo CliniccoreStrategic or Co-development Partner · 27 January 2026The Mayo Clinic in Rochester, Minnesota received an $82,405.70 grant to fund the first-ever clinical trial of psilocybin-assisted therapy for patients with brain tumors and existential distress. This represents a significant institutional validation of psychedelic therapy from a world-renowned medical center. Research leaders include Stacy D'Andre, MD and Ken Olivier, MD.
• PRATI & Pravan FoundationcoreStrategic or Co-development Partner · 27 January 2026PRATI and the Puerto Rico-based Pravan Foundation received a $75,000 grant to train 20 hospice workers, palliative care providers, and doulas to deliver psychedelic-assisted therapy for existential distress in Puerto Rico. Since 2019, PRATI has trained over 600 professionals worldwide through its Foundational KAP Training program. Puerto Rico has independent authority to reschedule psychedelic medicines.
• Red Willow HospicecoreStrategic or Co-development Partner · 27 January 2026Red Willow Hospice in Taos, New Mexico, the only accredited hospice in Northern New Mexico serving more than half the state, received a $100,000 grant to train hospice staff and provide ketamine-assisted psychotherapy (KAP) to terminally ill rural patients. The organization aims to implement KAP as a mind, body, and spirit-driven program rather than a medically driven one.
• Heal Ukraine TraumaminorStrategic or Co-development Partner · 27 January 2026Heal Ukraine Trauma, based in Cambridge, Massachusetts and Kyiv, Ukraine, received a $46,130 grant to expand trauma-informed group KAP training and services for veterans and their families affected by the war in Ukraine. With over 1.2 million registered veterans in Ukraine and an estimated 50% suffering mental health issues, this addresses a critical need in an underserved population.
• University of Washington MedicinecoreStrategic or Co-development Partner · 27 January 2026University of Washington Medicine received a $100,000 grant to pilot cost-effective group psilocybin therapy for cancer-related anxiety and depression during a multi-day retreat at The Whidbey Institute in Clinton, Washington. Research leaders include Anthony Back, MD and Bonnie McGregor, Ph.D. Findings will be published in a peer-reviewed journal.
• SafeHouse 7minorStrategic or Co-development Partner · 1 January 2024A prior grantee that breaks down access barriers to psychedelic treatment, training, and special projects, specifically targeting queer and BIPOC communities.
• Flourish (Columbia University and Golden Psychology)minorStrategic or Co-development Partner · 1 January 2024A research collaboration between Columbia University and Golden Psychology aimed at increasing safe, effective, and culturally responsive psychedelic-assisted therapy for transgender and gender-expansive communities. This was a 2024 grantee.
• Heroic Hearts ProjectminorStrategic or Co-development Partner · 1 January 2024A prior grantee that helps veterans overcome PTSD by providing access to psychedelic programs alongside professional coaching, peer support, and other empowering resources.
• Berkeley Center for the Science of PsychedelicsminorStrategic or Co-development Partner · 1 January 2024A prior grantee providing interdisciplinary training for advanced professionals from diverse backgrounds, emphasizing spiritual care, ancestral traditions, and increased access for LGBTQIA+ and BIPOC populations.
• IntegrateminorStrategic or Co-development Partner · 1 January 2024A prior grantee offering culturally responsive clinical and educational practices, leveraging psychedelic medicines for healing while eliminating financial barriers through fiscal sponsorship by Thank You Life.
• Naropa UniversityminorStrategic or Co-development Partner · 1 January 2024A prior grantee offering a range of public education opportunities focused on the transformative healing potential emerging in the psychedelic field.
• Caring for the CaregiversminorStrategic or Co-development Partner · 1 January 2024A prior grantee that organized a 3-day, 2-night social and educational retreat for up to 30 leaders from various psychedelic training programs across the USA.
• Unlimited SciencesminorStrategic or Co-development PartnerUnlimited Sciences is referenced as the organization measuring outcomes for the Home-Based Psychedelic and Spiritual Care (HBPS) pilot program, which will enroll 15 palliative and hospice patients across three sites for psychedelic-assisted therapy and spiritual care.
• Foundations and Academic InstitutionscoreStrategic or Co-development PartnerHHCM's strategic partnerships page states that its work depends on deep partnerships with foundations, academic institutions, healthcare systems, and mission-aligned businesses to expand access to psychedelic-assisted therapy and integrative care.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Beckley Foundation: UK-based foundation funding psychedelic science and drug policy reform, including psilocybin and ketamine studies. Comparable to HHCM as a grantmaking foundation channeling philanthropic capital into psychedelic therapy research and advocacy.
• Multidisciplinary Association for Psychedelic Studies (MAPS): Long-standing 501(c)(3) nonprofit that funds and conducts psychedelic therapy research, including MDMA-assisted therapy. Directly comparable to HHCM as a philanthropic, grant-issuing organization advancing psychedelic-assisted therapy through vetted research partnerships.
• Riverstyx Foundation: Consciousness-focused philanthropic foundation also associated with Robert Ansin. Operates in an adjacent philanthropic lane within psychedelic and contemplative science funding, making it a structurally similar peer foundation in the same founder ecosystem.
• Chacruna Institute: Nonprofit that produces education, conferences, and publications on psychedelics, with a particular focus on equity, Indigenous reciprocity, and cultural context. Comparable to HHCM as a values-driven nonprofit shaping access and dialogue around psychedelic-assisted healing.
• Heroic Hearts Project: Nonprofit that connects veterans with psychedelic therapy programs alongside coaching and peer support. A 2024 HHCM grantee and a peer as a community-rooted psychedelic nonprofit serving trauma and end-of-life-adjacent populations.
• Usona Institute: 501(c)(3) medical research nonprofit sponsoring psilocybin clinical trials and Open Science drug development. Comparable to HHCM as a psychedelic-focused nonprofit that channels philanthropic and academic dollars into clinical research infrastructure.

Emerging players

• Unlimited Sciences: Nonprofit that conducts psychedelic therapy outcomes research, currently serving as the outcome-measurement partner for HHCM's HBPS pilot. Functionally comparable as a smaller, data-driven nonprofit in the psychedelic palliative ecosystem, with partial rather than overlapping funding scope.
• Mind & Life Institute: Nonprofit that funds contemplative science research at the intersection of meditation, neuroscience, and mental health. Comparable to HHCM as a grantmaking nonprofit advancing evidence-based practices for mental and existential wellbeing, with philosophical overlap but a different funding focus.

Broad incumbents

• Cambia Health Foundation: Health-care philanthropy funding palliative care, pediatrics, and person-centered care system reform. Comparable to HHCM as a sizable regional health-care grantmaker advancing palliative care delivery, though it operates in a non-psychedelic frame.
• The John A. Hartford Foundation: Established private foundation focused on improving care for older adults, including serious illness and end-of-life care. Comparable to HHCM as a much larger grantmaking foundation whose end-of-life philanthropic mandate overlaps with HHCM's palliative focus, though it does not specifically fund psychedelic therapy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php?id=61586037459350
• LinkedInlinkedin.com/company/massinnovation-llc
• Instagraminstagram.com/stories/healingheartschangingminds

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healing Hearts Changing Minds